ondansetron has been researched along with Morbid Obesity in 9 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PONV was assessed in recovery and 24 hours after surgery in the ward." | 7.01 | Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial. ( Aghabagheri, M; Khajavi, MR; Najjari, K; Pourfakhr, P; Talebpour, M; Zabihi Mahmoudabadi, H, 2021) |
| "Postoperative nausea and vomiting is a major cause of patient dissatisfaction towards surgery." | 6.79 | Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. ( Goudra, BG; Ochroch, EA; Singh, PM; Sinha, AC; Williams, NW, 2014) |
| "PONV was assessed in recovery and 24 hours after surgery in the ward." | 3.01 | Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial. ( Aghabagheri, M; Khajavi, MR; Najjari, K; Pourfakhr, P; Talebpour, M; Zabihi Mahmoudabadi, H, 2021) |
| "Postoperative nausea and vomiting is a major cause of patient dissatisfaction towards surgery." | 2.79 | Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. ( Goudra, BG; Ochroch, EA; Singh, PM; Sinha, AC; Williams, NW, 2014) |
| "PONV was experienced by 74." | 1.91 | Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study). ( Abuyousif, YA; Aldossary, HM; Attia, M; El Hefnawy, E; El Nakeeb, A; Elmorshedi, M; Mohammed, MN; Rashad, AE; Salem, A; Zaid, A, 2023) |
| "PONV is a common and peculiar problem in bariatric surgery patients." | 1.48 | Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery. ( Bamgbade, OA; Khaw, RR; Oluwole, O, 2018) |
| " For the duration of 4 months, weight, body mass index, and the occurrence of adverse events was documented." | 1.48 | The safety and efficacy of the procedureless intragastric balloon. ( Al Haddad, E; Al Kendari, M; Al-Subaie, S; Almulla, A; Alsabah, S; Ekrouf, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rashad, AE | 1 |
| El Hefnawy, E | 1 |
| Elmorshedi, M | 1 |
| Abuyousif, YA | 1 |
| Salem, A | 1 |
| Attia, M | 1 |
| El Nakeeb, A | 1 |
| Zaid, A | 1 |
| Aldossary, HM | 1 |
| Mohammed, MN | 1 |
| Spaniolas, K | 1 |
| Nie, L | 1 |
| Moller, D | 1 |
| Tatarian, T | 1 |
| Hesketh, A | 1 |
| Yang, J | 1 |
| Docimo, S | 1 |
| Bates, A | 1 |
| Gan, TJ | 1 |
| Pryor, A | 1 |
| Pourfakhr, P | 1 |
| Aghabagheri, M | 1 |
| Zabihi Mahmoudabadi, H | 1 |
| Najjari, K | 1 |
| Talebpour, M | 1 |
| Khajavi, MR | 1 |
| Therneau, IW | 1 |
| Martin, EE | 1 |
| Sprung, J | 1 |
| Kellogg, TA | 1 |
| Schroeder, DR | 1 |
| Weingarten, TN | 1 |
| Bamgbade, OA | 1 |
| Oluwole, O | 1 |
| Khaw, RR | 1 |
| Alsabah, S | 1 |
| Al Haddad, E | 1 |
| Ekrouf, S | 1 |
| Almulla, A | 1 |
| Al-Subaie, S | 1 |
| Al Kendari, M | 1 |
| Ienca, R | 1 |
| Giardiello, C | 1 |
| Scozzarro, A | 1 |
| di Cola, RS | 1 |
| Di Lorenzo, N | 1 |
| Juneja, G | 1 |
| Lopez, G | 1 |
| Badiuddin, F | 1 |
| Sinha, AC | 1 |
| Singh, PM | 1 |
| Williams, NW | 1 |
| Ochroch, EA | 1 |
| Goudra, BG | 1 |
| Afaneh, C | 1 |
| Costa, R | 1 |
| Pomp, A | 1 |
| Dakin, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery: a Randomized Clinical Trial[NCT05087615] | Phase 3 | 130 participants (Actual) | Interventional | 2021-03-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for ondansetron and Morbid Obesity
| Article | Year |
|---|---|
A Comprehensive Approach for the Prevention of Nausea and Vomiting Following Sleeve Gastrectomy: a Randomized Controlled Trial.
Topics: Antiemetics; Double-Blind Method; Gastrectomy; Humans; Obesity, Morbid; Ondansetron; Prospective Stu | 2020 |
Prophylactic Administration of Diphenhydramine/Acetaminophen and Ondansetron Reduced Postoperative Nausea and Vomiting and Pain Following Laparoscopic Sleeve Gastrectomy: a Randomized Controlled Trial.
Topics: Acetaminophen; Antiemetics; Diphenhydramine; Double-Blind Method; Gastrectomy; Humans; Laparoscopy; | 2021 |
Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride.
Topics: Adult; Antiemetics; Female; Gastric Balloon; Humans; Male; Middle Aged; Obesity, Morbid; Ondansetron | 2019 |
Aprepitant's prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery.
Topics: Adult; Antiemetics; Aprepitant; Bariatric Surgery; Double-Blind Method; Drug Therapy, Combination; F | 2014 |
A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Follow-Up Studies; Gastrectomy; Gastroesophag | 2015 |
4 other studies available for ondansetron and Morbid Obesity
| Article | Year |
|---|---|
Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study).
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Dexamethasone; Female; Gastrectomy; Gastroesophageal Re | 2023 |
The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
Topics: Adult; Aged; Antiemetics; Aprepitant; Bariatric Surgery; Chemoprevention; Dexamethasone; Double-Blin | 2018 |
Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery.
Topics: Adult; Antiemetics; Bariatric Surgery; Chemoprevention; Critical Pathways; Dexamethasone; Drug Admin | 2018 |
The safety and efficacy of the procedureless intragastric balloon.
Topics: Adult; Antiemetics; Body Mass Index; Drug Therapy, Combination; Female; Gastric Balloon; Humans; Kuw | 2018 |